门诊艾滋病病毒感染者中的结核病筛查:系统综述与个体参与者数据荟萃分析
该系统综述与个体参与者数据荟萃分析纳入22项研究共15666例门诊艾滋病病毒感染者,评估替代筛查试验及策略对结核病的诊断准确性。结果显示,C反应蛋白(≥10 mg/L)与W4SS敏感性相似但特异性更高;WHO推荐算法敏感性58%,Xpert for all敏感性68%;在ART门诊患者中,W4SS联合胸部X线异常平行策略敏感性高于W4SS单独。
要点
- W4SS敏感性82%、特异性42%;C反应蛋白(≥10 mg/L)敏感性77%、特异性74%。
- WHO推荐算法敏感性58%、特异性99%;Xpert for all敏感性68%、特异性99%。
- ART门诊患者中,W4SS联合胸部X线异常平行策略敏感性89%、特异性33%。
核心结论
- C反应蛋白可减少进一步快速诊断检测的需求而不影响敏感性,已纳入更新的WHO结核病筛查指南。
- C反应蛋白在ART门诊患者中的数据稀少,需未来研究其在该人群中的效用。
- 胸部X线在ART门诊患者中与W4SS联合时可能有用。
- WHO推荐算法敏感性欠佳;Xpert for all敏感性略有提高但将有重大资源影响。
研究设计与样本
- 系统综述与个体参与者数据荟萃分析,检索PubMed(MEDLINE)、Embase、Cochrane图书馆及会议摘要,检索时间从2011年1月1日至2019年8月2日。
- 纳入成年和青少年(年龄≥10岁)门诊艾滋病病毒感染者的前瞻性横断面观察性研究和随机试验。
- 共鉴定25项研究,获得22项研究数据(包括15666例参与者;15663例有数据参与者中4347例[27.7%]正在接受ART)。
- 参考标准为培养。研究注册于PROSPERO,CRD42020155895。
主要发现
- W4SS敏感性82%(95%CI 72-89),特异性42%(95%CI 29-57)。
- C反应蛋白(≥10 mg/L)敏感性77%(95%CI 61-88),与W4SS相似;特异性74%(95%CI 61-83;n=3571),高于W4SS。
- 咳嗽(持续≥2周)、血红蛋白(<10 g/dL)、体重指数(<18.5 kg/m2)和淋巴结病具有高特异性(80-90%)但低敏感性(29-43%)。
- WHO推荐算法敏感性58%(95%CI 50-66),特异性99%(95%CI 98-100);Xpert for all敏感性68%(95%CI 57-76),特异性99%(95%CI 98-99)。
- 在同时评估两者的唯一研究中,痰Xpert Ultra敏感性高于痰Xpert(73%[95%CI 62-81] vs 57%[95%CI 47-67]),特异性相似(98%[95%CI 96-98] vs 99%[95%CI 98-100])。
关键数值与推荐
- WHO推荐的门诊艾滋病病毒感染者结核病筛查与诊断算法为:W4SS阳性后行WHO推荐的分子快速诊断检测(如Xpert MTB/RIF)。
- C反应蛋白(≥10 mg/L)已纳入更新的WHO结核病筛查指南。
临床怎么用
- C反应蛋白可减少进一步快速诊断检测的需求而不影响敏感性,已纳入更新的WHO结核病筛查指南。
- 胸部X线在ART门诊患者中与W4SS联合时可能有用。
- WHO推荐算法敏感性欠佳;Xpert for all敏感性略有提高但将有重大资源影响。
- C反应蛋白在ART门诊患者中的数据稀少,需未来研究其在该人群中的效用。
局限性
- C反应蛋白数据在ART门诊患者中稀少,需未来研究其在该人群中的效用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The WHO-recommended tuberculosis screening and diagnostic algorithm in ambulatory people living with HIV is a four-symptom screen (known as the WHO-recommended four symptom screen [W4SS]) followed by a WHO-recommended molecular rapid diagnostic test (eg Xpert MTB/RIF [hereafter referred to as Xpert]) if W4SS is positive. To inform updated WHO guidelines, we aimed to assess the diagnostic accuracy of alternative screening tests and strategies for tuberculosis in this population. METHODS: In this systematic review and individual participant data meta-analysis, we updated a search of PubMed (MEDLINE), Embase, the Cochrane Library, and conference abstracts for publications from Jan 1, 2011, to March 12, 2018, done in a previous systematic review to include the period up to Aug 2, 2019. We screened the reference lists of identified pieces and contacted experts in the field. We included prospective cross-sectional, observational studies and randomised trials among adult and adolescent (age ≥10 years) ambulatory people living with HIV, irrespective of signs and symptoms of tuberculosis. We extracted study-level data using a standardised data extraction form, and we requested individual participant data from study authors. We aimed to compare the W4SS with alternative screening tests and strategies and the WHO-recommended algorithm (ie, W4SS followed by Xpert) with Xpert for all in terms of diagnostic accuracy (sensitivity and specificity), overall and in key subgroups (eg, by antiretroviral therapy [ART] status). The reference standard was culture. This study is registered with PROSPERO, CRD42020155895. FINDINGS: We identified 25 studies, and obtained data from 22 studies (including 15 666 participants; 4347 [27·7%] of 15 663 participants with data were on ART). W4SS sensitivity was 82% (95% CI 72-89) and specificity was 42% (29-57). C-reactive protein (≥10 mg/L) had similar sensitivity to (77% [61-88]), but higher specificity (74% [61-83]; n=3571) than, W4SS. Cough (lasting ≥2 weeks), haemoglobin (<10 g/dL), body-mass index (<18·5 kg/m2), and lymphadenopathy had high specificities (80-90%) but low sensitivities (29-43%). The WHO-recommended algorithm had a sensitivity of 58% (50-66) and a specificity of 99% (98-100); Xpert for all had a sensitivity of 68% (57-76) and a specificity of 99% (98-99). In the one study that assessed both, the sensitivity of sputum Xpert Ultra was higher than sputum Xpert (73% [62-81] vs 57% [47-67]) and specificities were similar (98% [96-98] vs 99% [98-100]). Among outpatients on ART (4309 [99·1%] of 4347 people on ART), W4SS sensitivity was 53% (35-71) and specificity was 71% (51-85). In this population, a parallel strategy (two tests done at the same time) of W4SS with any chest x-ray abnormality had higher sensitivity (89% [70-97]) and lower specificity (33% [17-54]; n=2670) than W4SS alone; at a tuberculosis prevalence of 5%, this strategy would require 379 more rapid diagnostic tests per 1000 people living with HIV than W4SS but detect 18 more tuberculosis cases. Among outpatients not on ART (11 160 [71·8%] of 15 541 outpatients), W4SS sensitivity was 85% (76-91) and specificity was 37% (25-51). C-reactive protein (≥10 mg/L) alone had a similar sensitivity to (83% [79-86]), but higher specificity (67% [60-73]; n=3187) than, W4SS and a sequential strategy (both test positive) of W4SS then C-reactive protein (≥5 mg/L) had a similar sensitivity to (84% [75-90]), but higher specificity than (64% [57-71]; n=3187), W4SS alone; at 10% tuberculosis prevalence, these strategies would require 272 and 244 fewer rapid diagnostic tests per 1000 people living with HIV than W4SS but miss two and one more tuberculosis cases, respectively. INTERPRETATION: C-reactive protein reduces the need for further rapid diagnostic tests without compromising sensitivity and has been included in the updated WHO tuberculosis screening guidelines. However, C-reactive protein data were scarce for outpatients on ART, necessitating future research regarding the utility of C-reactive protein in this group. Chest x-ray can be useful in outpatients on ART when combined with W4SS. The WHO-recommended algorithm has suboptimal sensitivity; Xpert for all offers slight sensitivity gains and would have major resource implications. FUNDING: World Health Organization.
引用
- Dhana A, Hamada Y, Kengne AP, et al. Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis. Lancet Infect Dis. 2021. PMID: 34800394. doi:10.1016/S1473-3099(21)00387-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。